OnKure Therapeutics, Inc.
NASDAQ:OKUR · NASDAQ Global Market
-$0.05 today
Vol 0.12M · Avg 0.34M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+80.17%
Period High
$5.27
Period Low
$2.00
Latest
$4.36
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Mersana Therapeutics, Inc.
MRSN
$145.36M
PDS Biotechnology Corporation
NASDAQ:PDSB
$58.61M
Xilio Therapeutics, Inc.
NASDAQ:XLO
$54.64M
Kezar Life Sciences, Inc.
KZR
$53.86M
FibroGen, Inc.
FGEN
$36.69M
Aligos Therapeutics, Inc.
ALGS
$32.67M
Actinium Pharmaceuticals, Inc.
ATNM
$31.69M
Barinthus Biotherapeutics plc
BRNS
$27.41M
CEL-SCI Corporation
CVM
$7.42M
Tempest Therapeutics, Inc.
TPST
$5.60M
What is the latest OKUR filing?
The latest filing shown is 4 dated Jun 8, 2026.
How many recent filings does OKUR have?
Intrinsic Alpha currently shows 20 recent filings for OKUR.
Explore More
Continue the stock analysis
Jump to another research area for this company.